CLSD: Clearside Biomedical, Inc. Stock

by  •  • Comments Off on CLSD: Clearside Biomedical, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 56.91
Enterprise Value ($M) 96.73
Book Value ($M) -45.91
Book Value / Share -0.60
Price / Book -1.24
NCAV ($M) -51.95
NCAV / Share -0.68
Price / NCAV -1.10

Profitability (mra)
Return on Invested Capital (ROIC) -3.78
Return on Assets (ROA) -0.77
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.72
Current Ratio 2.72

Balance Sheet (mrq) ($M)
Current Assets 13.63
Assets 19.67
Liabilities 65.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.66
Operating Income -28.88
Net Income -34.35
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -24.70
Cash from Investing -0.64
Cash from Financing 16.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13G Wiles Stephen Boyd 5.20
03-04 13G/A Whitmore Bradford T 8.60 4.13
02-21 13D/A Hatteras Venture Advisors IV SBIC, LLC 0.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-15 10-Q The Company’s amended and restated certificate of incorporation authorizes the Company to issue 200,000,000 shares of $0.001 par value common stock. As of March 31, 2025 and December 31, 2024, there were 77,272,786 and 76,578,383 shares of common sto
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-02 39,691 110,321 35.98
2025-05-30 37,887 150,713 25.14
2025-05-29 68,737 250,137 27.48
2025-05-28 71,802 313,277 22.92

(click for more detail)

Similar Companies
CADL – Candel Therapeutics, Inc. CARM – Carisma Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc. CLYM – Climb Bio, Inc.
CRMD – CorMedix Inc.


Financial data and stock pages provided by
Fintel.io